The STD market growth is strongly driven by high incidence rates and increase in prevalence rates of STDs such as chlamydia, syphilis, and gonorrhea. Moreover, implementation of national screening programs to improve and increase the STD diagnosis in many key geographies such as U.S., UK, Canada, and support in reimbursement for STDs testing are further supporting the sexually transmitted diseases (STD) testing market growth. However, there is social stigma associated with patients visiting specialized STD clinics which refrain patients from STD diagnosis. Moreover, huge proportion of patients infected with STDs are based in out-of-reach geographic areas which significantly limits the diagnosis of STDs. Such factors are expected to restrain the STD testing market growth.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
This report provides comprehensive competitive analysis and profiles of prominent market players such as Abbott laboratories, Becton Dickinson Company, BioMérieux, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Diasorin Molecular LLC, Hologic, Inc., Orasure Technologies, Inc., Roche Holding AG and Thermo Fisher Scientific Inc.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1775
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
- By intubation, the orotracheal intubation segment held the largest sexually transmitted diseases (STD) testing market share in 2020 and is expected to remain dominant during the forecast period.
- By application, the anesthesia segment held the largest market share in 2020 and is expected to remain dominant during the forecast period.
- By end user, the hospitals segment held the largest sexually transmitted diseases testing market share in 2020 and is expected to remain dominant during the forecast period.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/1775
At present, STDs are considered as one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent STDs. The STD testing market has gained prominence in the recent years due to high prevalence of major STDs worldwide and as a result, increase in need for STD diagnosis. However, limited access to STD diagnosis in majority of the population from developing regions is expected to restrain the sexually transmitted diseases (STD) testing market growth.
By disease type, the chlamydia testing segment is the highest revenue contributor and gonorrhea segment is expected to exhibit the fastest growth rate of 7.3%. This is attributed to the increased prevalence of gonorrhea in the last decade.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060